Electroconvulsive therapy (ECT) is a less targeted method of brain stimulation that has been used in cases of severe and treatment-resistant mental disorders, including depression, schizophrenia ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Transcranial Magnetic Stimulator Market has witnessed remarkable growth in recent years. Valued at USD 1.22 billion in ...

Major depressive disorder (MDD), also referred to as clinical depression or depression, is a mood disorder where a person has a consistently low or depressed mood and no longer finds interest in ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD ... magnetic stimulation, electroconvulsive therapy, or augmentation with olanzapine.” ...

The weeklong trial of former Elberon Public Library Director Bailey Anne Jenkins concluded last Friday as a Tama County jury ...

Vivien Leigh, who played Scarlett O'Hara in "Gone with the Wind," died in 1967 at age 53 from tuberculosis. She also starred ...

Feeling down, anxious, or not like your usual self can be a sign of a mental health problem. These feelings might make it ...

It’s 2025, but the abuse of people living myalgic encephalomyelitis (ME/CFS) continues unabated. Already, less than a month ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Scientists at Virginia Tech are revolutionizing depression treatment by tapping into how the brain processes rewards. Their ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...